Brief: ChromaDex Announces Issuance Of New U.S. Patent On NRH, NARH

Niagen Bioscience

22/02/2023 14:39

Feb 22 (Reuters) - ChromaDex Corp  CDXC.O :
    * CHROMADEX ANNOUNCES ISSUANCE OF NEW U.S. PATENT ON
DIHYDRONICOTINAMIDE RIBOSIDE (NRH) AND DIHYDRONICOTINIC ACID
RIBOSIDE (NARH), FURTHER SOLIDIFYING CHROMADEX AS THE LEADER IN
THE NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) PRECURSOR SPACE
    * CHROMADEX CORP - PATENT WILL PROVIDE CHROMADEX PROTECTION
FOR
NRH AND NARH UNTIL 2034

Source text for Eikon:  ID:nBw3ndfTja 
Further company coverage:  CDXC.O 
 ((Reuters.Briefs@thomsonreuters.com;))